Skip to content
Open access

A novel pH-responsive nanoreactor for pyroptosis induction: multifaceted ROS amplification drives potent immunotherapy against triple-negative breast cancer

Jul 2026 · Journal of Nanobiotechnology · Vol 24 · 0 citations · 64 references
Medicine

TL;DR

A pH-responsive, pyroptosis-inducing nanoreactor, ZnS/ZIF-90:Fe/Vk3 (ZZFV), designed to elicit potent antitumor immunity, demonstrates potent antitumor efficacy, effectively overcoming immune tolerance in TNBC and achieving robust, sustained antitumor immunity.

Abstract

Triple-negative breast cancer (TNBC) is associated with rapid progression and poor sensitivity to monotherapies, necessitating combination strategies to enhance tumor immunogenicity, reprogram the tumor microenvironment (TME), and convert immunologically “cold” tumors into “hot” ones. In this study, we develop a pH-responsive, pyroptosis-inducing nanoreactor, ZnS/ZIF-90:Fe/Vk3 (ZZFV), designed to elicit potent antitumor immunity. Under acidic conditions, ZZFV rapidly degrades, releasing Zn2+, Fe2+, H2S, and Vk3. H2S promotes glucose uptake and consumption while downregulating cytochrome c oxidase subunit IV (COX IV) expression, whereas Zn2+ suppresses lactate dehydrogenase (LDH) activity, collectively disrupting glucose metabolism and exacerbating intracellular acidification. Meanwhile, NAD(P)H quinone oxidoreductase 1 (NQO1), highly expressed in tumor cells, catalyzes the conversion of Vk3 to H2O2, which is subsequently converted to highly toxic •OH through Fe2+-mediated Fenton reactions. Additionally, Zn2+ and H2S synergistically disrupt mitochondrial function, thereby amplifying reactive oxygen species (ROS) production. Excessive ROS triggers Caspase-1–dependent pyroptosis, leading to the liberation of damage-associated molecular patterns. These events promote dendritic cell (DC) maturation, robust T-cell activation, M1 macrophage polarization, and expansion of central memory T-cell populations, thereby conferring durable immune protection. Consequently, ZZFV demonstrates potent antitumor efficacy, effectively overcoming immune tolerance in TNBC and achieving robust, sustained antitumor immunity.

Read PDF

Similar papers

Open access Aug 2026

Photocontrolled nanosystem potentiates photo-chemoimmunotherapy against TNBC by integrating apoptosis/ferroptosis/ pyroptosis and STING activation

A spatiotemporally regulated organelle-targeted nanoplatform, IR820-GEM@MIL101 (IGM), is developed, providing a promising strategy for light-regulated combinatorial immunotherapy against aggressive malignancies.

Pan Zhang, Ming-Lun Liu, Lei Huang et al. · 0 citations
Sep 2026

A Metabolic Nanoplatform Potentiates Triple-Negative Breast Cancer Radiosensitivity via Disrupting Carbonic Anhydrase IX/Pentose Phosphate Pathway Crosstalk.

Radiotherapy resistance in tumors driven by metabolic adaptations within acidic microenvironments involves the upregulation of both carbonic anhydrase IX (CA IX) and the pentose phosphate pathway (PPP) as well as the functional crosstalk between them. To overcome this, we developed a polyvinylpyrrolidone (PVP)-modified...

Zhi-Li Ma, Bin Zhao, Yun Wang et al. · 0 citations
Sep 2026

NQO1‑activated self‑reinforcing bimetallic nanoplatform triggers ferroptosis and cuproptosis for osteosarcoma therapy.

The CFCM/VK3 nanoplatform demonstrates significant tumor suppression and excellent biosafety in an osteosarcoma mouse model, establishing a new paradigm of metal-ion interference therapy that leverages the mutual dependency between iron and copper for self-amplifying antitumor effects.

Ye Zhang, Qing-Qing Bai, Yan-Hua Zhong et al. · 0 citations
Open access Aug 2026

A universal consuming endogenous H2S strategy using bismuth-metal-organic nanocapsule networks for overcoming osteosarcoma cisplatin resistance

This study identifies endogenous H2S as a key driver of cisplatin resistance in osteosarcoma and develops a novel H2S-targeting theranostic platform named bismuth-based metal-organic nanocapsule network (Bi-MONC), offering a universal approach to scavenge intracellular H2S.

Yi-Xuan Lin, Kai Yuan, Yi-Hao Liu et al. · 0 citations
Open access Aug 2026

A dual-ion/immune checkpoint nanoplatform-activated pyroptosis/cGAS-STING signaling transform iMWA into systemic immunotherapy against HCC recurrence

An ion-based immunomodulatory paradigm integrating ICD, innate immune activation, and immune checkpoint blockade is established, offering a promising nanotherapeutic framework for preventing post-ablation HCC recurrence and enhancing immunotherapy in solid tumors.

Mengqi Zhang, Chao Rong, Hejia Qin et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.